Brickroad
Brickroad
IndexSignalsBlog
/Index//

Product

  • Information Frontier Agent
  • Vendor Management Agent
  • Product Tour
  • Pricing

Solutions

  • All Solutions
  • Atlas
  • Wayfinder
  • Horizon

Suppliers

  • Sell Your Data
  • Start Onboarding
  • Programmatic Data License

Community

  • Public Index
  • Signals
  • Blog

Company

  • About
  • Team
  • Careers
  • Brand

Connect

  • LinkedIn
  • X
PrivacyTermsCookies

© 2026 Brickroad

/Index/Rxss/Two layered assets, the second of which is the genuinely non-obvious one
R

Two layered assets, the second of which is the genuinely non-obvious one

RXSSManage supplier listing

Two layered assets, the second of which is the genuinely non-obvious one. (1) A pharmacy claims and drug-price panel: 175 million pharmacy claims analyzed annually across 19 million covered members and 60+ client organizations, carrying real-time price and out-of-pocket cost information throughout the medication journey, with the clinical technology that generates them described as patented. (2) A therapeutic-alternative decision dataset produced as pure byproduct of the engagement workflow: 75,000+ clinical savings suggestions have been issued, each pairing a member's current prescription with one or more lower-cost clinically appropriate alternatives, and each recording whether the member accepted — roughly 1 in 2 engaged members changes to a lower-cost option — together with the time to decision, measured at an average of 49 seconds to switch a prescription. That is a labeled, outcome-complete record of medication substitution under cost pressure: recommended alternative, accepted or declined, decision latency, and the realized out-of-pocket and plan-spend delta. Layered on top is first-party engagement and support exhaust (member outreach, counseling interactions, activation campaigns run for plan sponsors) plus plan-level analytics used for GLP-1 utilization and pharmacy cost-containment work.

Rxss/Two layered assets, the second of which is the genuinely non-obvious one
SampleCoverage

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Rxss and files the sample in your catalog — private to you.

Start 7-day trial→Nothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry
Managed CareHealth Care Technology
Instruments
equities
Categories
Alternative
Open buyer room →
Price
Fundamental
Sentiment
Regions
US
Sample tickers
CVSCORUNHELVLLYNVOHIMS
Dataset card
Type
not stated
Format
Tabular claims and price records plus structured event logs: claim-level pharmacy records keyed to member, drug and pharmacy; a recommendation-event table (original drug, recommended alternative(s), presented price and out-of-pocket delta, acceptance flag, decision timestamp and latency, realized cost change); and engagement/support interaction logs. Delivered through a member-facing platform and plan dashboards; presented as an engagement platform rather than a standalone API product.
Volume
175 million pharmacy claims analyzed annually across 19 million members and 60+ client organizations; 75,000+ clinical savings suggestions with recorded acceptance outcomes and decision timestamps; real-time price and out-of-pocket comparisons across the medication journey; plus accumulated engagement and support interaction logs and plan-level cost analytics
Users
19 million covered members with access, of which a smaller engaged subset is active (the company states 19 million covered members and 60+ major clients; it separately frames outcomes per 'engaged member', confirming that covered population materially exceeds engaged users)
History
not stated
Update frequency
not stated
Growth
Active — current-year content through April 2026, a published speaking presence at the Conference Board's 26th Annual Employee Health Care Conference, an ongoing thought-leadership cadence on pharmacy cost transparency and GLP-1 utilization, and a refresh cadence on homepage impact metrics indicating live measurement
Launched
~2010-2013 (inferred: no launch year stated on the homepage; the company profile records 250 employees, ~$33M revenue and a $621M cumulative funding/transaction history at merger-or-acquisition stage, and the product holds granted patents on its clinical technology, all of which require a multi-year operating runway — consistent with an established firm rather than a recent launch)
Delivery
not stated
Entity mapping
not stated
Sample
not stated
Point-in-time
not stated
Licence
not stated

supplier index read from their site

Rxss has not added their own details yet. Not yet on file:

  • Dataset
  • Data dictionary
  • Coverage
  • Provenance
  • Rights & data handling